Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
36
AMAT Quote, Financials, Valuation and Earnings
Last price:
$137.4500
Seasonality move
:
8.39%
Day range:
$143.8400 - $149.3100
52-week range:
$141.1600 - $255.8900
Dividend yield:
1.08%
P/E ratio:
19.31x
P/S ratio:
4.44x
P/B ratio:
6.45x
Volume:
4.8M
Avg. volume:
6.9M
1-year change:
-28.32%
Market cap:
$120B
Revenue:
$27.2B
EPS (TTM):
$7.65
Analysts' Opinion
-
Consensus RatingApplied Materials has received a consensus rating of Buy. The company's average rating is a Buy based on 20 Buy ratings, 10 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $206.3200, Applied Materials has an estimated upside of 39.64% from its current price of $147.7500.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $164.0000 representing 100% downside risk from its current price of $147.7500.
Fair Value
-
According to the consensus of 31 analysts, Applied Materials has 39.64% upside to fair value with a price target of $206.3200 per share.
AMAT vs. S&P 500
-
Over the past 5 trading days, Applied Materials has underperformed the S&P 500 by -3.5% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Applied Materials does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Applied Materials has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Applied Materials reported revenues of $7.2B.
Earnings Growth
-
Applied Materials earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Applied Materials reported earnings per share of $1.45.
Enterprise value:
118.1B
EV / Invested capital:
4.75x
Price / LTM sales:
4.44x
EV / EBIT:
14.37x
EV / Revenue:
4.27x
PEG ratio (5yr expected):
3.47x
EV / Free cash flow:
19.90x
Price / Operating cash flow:
20.66x
Enterprise value / EBITDA:
13.69x
Gross Profit (TTM):
$13.2B
Return On Assets:
19.24%
Net Income Margin (TTM):
22.95%
Return On Equity:
34.44%
Return On Invested Capital:
26%
Operating Margin:
30.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $26.3B | $26.5B | $27.6B | $6.7B | $7.2B | |
| Gross Profit | $12.2B | $12.4B | $13.2B | $3.2B | $3.5B | |
| Operating Income | $7.8B | $7.7B | $8.1B | $2B | $2.2B | |
| EBITDA | $8.3B | $8.9B | $8.6B | $2.5B | $2.3B | |
| Diluted EPS | $7.46 | $8.50 | $7.65 | $2.41 | $1.45 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $14.3B | $15.7B | $16.7B | $19.2B | $20.7B | |
| Total Assets | $23.3B | $25.4B | $28B | $31.5B | $33.3B | |
| Current Liabilities | $4.5B | $6.3B | $7.3B | $7.1B | $7.7B | |
| Total Liabilities | $11.8B | $13.5B | $14.5B | $14.1B | $14.7B | |
| Total Equity | $11.5B | $11.9B | $13.4B | $17.4B | $18.6B | |
| Total Debt | $5.4B | $5.5B | $5.7B | $5.6B | $6.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5B | $8.8B | $7.3B | $2.3B | $925M | |
| Cash From Investing | -$1.5B | -$1.7B | -$2.8B | -$447M | -$897M | |
| Cash From Financing | -$5.2B | -$3.8B | -$5.1B | -$1.2B | -$1.8B | |
| Free Cash Flow | $4.1B | $7.7B | $5.9B | $2.1B | $544M | |
AMAT
Sector
Market Cap
$120B
$83.5M
Price % of 52-Week High
57.74%
58.46%
Dividend Yield
1.08%
0%
Shareholder Yield
3.61%
0.8%
1-Year Price Total Return
-28.32%
-19.05%
Beta (5-Year)
1.609
0.881
Dividend yield:
1.08%
Annualized payout:
$1.44
Payout ratio:
19.74%
Growth streak:
7 years
Technicals
8-day SMA
Sell
Level
$148.8175
200-day SMA
Sell
Level
$188.4001
Bollinger Bands (100)
Sell
Level
157.6008 - 183.2608
Chaikin Money Flow
Buy
Level
110M
20-day SMA
Sell
Level
$151.2335
Relative Strength Index (RSI14)
Sell
Level
39.2165
ADX Line
Sell
Level
26.7074
Williams %R
Neutral
Level
-58.9408
50-day SMA
Sell
Level
$166.3436
MACD (12, 26)
Sell
Level
-4.9796
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-86.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.8441)
Buy
CA Score
(Annual)
Level (1.221)
Buy
Beneish M-Score
(Annual)
Level (-2.6402)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-3.1494)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.
Stock Forecast FAQ
In the current month, AMAT has received 20 Buy ratings 10 Hold ratings, and 1 Sell ratings. The AMAT average analyst price target in the past 3 months is $206.3200.
-
Where Will Applied Materials Stock Be In 1 Year?
According to analysts, the consensus estimate is that Applied Materials share price will rise to $206.3200 per share over the next 12 months.
-
What Do Analysts Say About Applied Materials?
Analysts are divided on their view about Applied Materials share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Applied Materials is a Sell and believe this share price will drop from its current level to $164.0000.
-
What Is Applied Materials's Price Target?
The price target for Applied Materials over the next 1-year time period is forecast to be $206.3200 according to 31 Wall Street analysts, 20 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is AMAT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Applied Materials is a Buy. 20 of 31 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AMAT?
You can purchase shares of Applied Materials via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Applied Materials shares.
-
What Is The Applied Materials Share Price Today?
Applied Materials was last trading at $137.4500 per share. This represents the most recent stock quote for Applied Materials. Yesterday, Applied Materials closed at $147.7500 per share.
-
How To Buy Applied Materials Stock Online?
In order to purchase Applied Materials stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 7.22% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 10.03% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 5.98% over the past day.
